Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Alexandra Walls and David Veesler.
Connection Strength

9.553
  1. Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion. Cell. 2020 Dec 10; 183(6):1732.
    View in: PubMed
    Score: 0.918
  2. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020 Dec 10; 183(6):1735.
    View in: PubMed
    Score: 0.918
  3. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020 04 16; 181(2):281-292.e6.
    View in: PubMed
    Score: 0.871
  4. Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion. Cell. 2019 02 21; 176(5):1026-1039.e15.
    View in: PubMed
    Score: 0.807
  5. Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion. Proc Natl Acad Sci U S A. 2017 10 17; 114(42):11157-11162.
    View in: PubMed
    Score: 0.736
  6. Crucial steps in the structure determination of a coronavirus spike glycoprotein using cryo-electron microscopy. Protein Sci. 2017 01; 26(1):113-121.
    View in: PubMed
    Score: 0.689
  7. Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy. Nat Struct Mol Biol. 2016 Oct; 23(10):899-905.
    View in: PubMed
    Score: 0.684
  8. Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer. Nature. 2016 Mar 03; 531(7592):114-117.
    View in: PubMed
    Score: 0.656
  9. Broad betacoronavirus neutralization by a stem helix-specific human antibody. Science. 2021 09 03; 373(6559):1109-1116.
    View in: PubMed
    Score: 0.240
  10. SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern. Science. 2021 08 06; 373(6555):648-654.
    View in: PubMed
    Score: 0.238
  11. Structural basis for broad coronavirus neutralization. Nat Struct Mol Biol. 2021 06; 28(6):478-486.
    View in: PubMed
    Score: 0.236
  12. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell. 2021 04 29; 184(9):2332-2347.e16.
    View in: PubMed
    Score: 0.234
  13. Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2. Cell. 2020 11 25; 183(5):1367-1382.e17.
    View in: PubMed
    Score: 0.228
  14. Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology. Cell. 2020 11 12; 183(4):1024-1042.e21.
    View in: PubMed
    Score: 0.226
  15. Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation. Nat Struct Mol Biol. 2020 10; 27(10):942-949.
    View in: PubMed
    Score: 0.224
  16. Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors. Nat Struct Mol Biol. 2019 12; 26(12):1151-1157.
    View in: PubMed
    Score: 0.214
  17. Structural basis for human coronavirus attachment to sialic acid receptors. Nat Struct Mol Biol. 2019 06; 26(6):481-489.
    View in: PubMed
    Score: 0.206
  18. Glycan Shield and Fusion Activation of a Deltacoronavirus Spike Glycoprotein Fine-Tuned for Enteric Infections. J Virol. 2018 02 15; 92(4).
    View in: PubMed
    Score: 0.188
  19. Vitrification after multiple rounds of sample application and blotting improves particle density on cryo-electron microscopy grids. J Struct Biol. 2017 04; 198(1):38-42.
    View in: PubMed
    Score: 0.176
  20. Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies. Nature. 2021 10; 598(7880):342-347.
    View in: PubMed
    Score: 0.060
  21. Discovery and Characterization of Spike N-Terminal Domain-Binding Aptamers for Rapid SARS-CoV-2 Detection. Angew Chem Int Ed Engl. 2021 09 20; 60(39):21211-21215.
    View in: PubMed
    Score: 0.060
  22. Broad sarbecovirus neutralization by a human monoclonal antibody. Nature. 2021 09; 597(7874):103-108.
    View in: PubMed
    Score: 0.060
  23. SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape. Nature. 2021 09; 597(7874):97-102.
    View in: PubMed
    Score: 0.060
  24. Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design. Front Immunol. 2021; 12:710263.
    View in: PubMed
    Score: 0.060
  25. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020. Nature. 2021 07; 595(7869):707-712.
    View in: PubMed
    Score: 0.059
  26. Adjuvanting a subunit COVID-19 vaccine to induce protective immunity. Nature. 2021 06; 594(7862):253-258.
    View in: PubMed
    Score: 0.059
  27. Designed proteins assemble antibodies into modular nanocages. Science. 2021 04 02; 372(6537).
    View in: PubMed
    Score: 0.059
  28. Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies. Nature. 2021 05; 593(7857):136-141.
    View in: PubMed
    Score: 0.058
  29. De novo design of picomolar SARS-CoV-2 miniprotein inhibitors. Science. 2020 10 23; 370(6515):426-431.
    View in: PubMed
    Score: 0.056
  30. Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak. Nat Commun. 2020 09 01; 11(1):4378.
    View in: PubMed
    Score: 0.056
  31. Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell. 2020 09 03; 182(5):1295-1310.e20.
    View in: PubMed
    Score: 0.056
  32. An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates. Sci Transl Med. 2020 08 05; 12(555).
    View in: PubMed
    Score: 0.056
  33. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature. 2020 07; 583(7815):290-295.
    View in: PubMed
    Score: 0.055
  34. Automatically Fixing Errors in Glycoprotein Structures with Rosetta. Structure. 2019 01 02; 27(1):134-139.e3.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.